16 (S) -HETE
16 (S) -HETE is an endogenous inhibitor of neutrophil activity and can be used in the study of acute ischemic brain injury[1].
Product Specifications
CAS Number
[183509-23-1]
UNSPSC
12352211
Hazard Statement
H225-H319
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/16-s-hete.html
Solubility
10 mM in DMSO
Smiles
OC(CCC/C=C\C/C=C\C/C=C\C/C=C\[C@@H](O)CCCC)=O
Molecular Formula
C20H32O3
Molecular Weight
320.47
Precautions
P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P370+P378-P403+P235-P501
References & Citations
[1]Reddy Y K, et al. Practical, asymmetric synthesis of 16-hydroxyeicosa-5 (Z), 8 (Z), 11 (Z), 14 (Z) -tetraenoic acid (16-HETE), an endogenous inhibitor of neutrophil activity[J]. Bioorganic & medicinal chemistry letters, 2003, 13 (21) : 3719-3720.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
